Your browser doesn't support javascript.
loading
Outcomes of intermediate or high-risk CMML patients treated with hypomethylating agents combined with venetoclax: A single center experience.
Li, Chao; Deng, ChengXin; Wu, Ping; Liu, KaiFan; Huang, Xin; Li, MingMin; Chen, XiaoMei; Geng, SuXia; Lai, PeiLong; Weng, JianYu; Du, Xin.
Afiliação
  • Li C; School of Medicine, South China University of Technology, Guangzhou, China.
  • Deng C; Department of Hematology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
  • Wu P; Department of Hematology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
  • Liu K; Department of Hematology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
  • Huang X; School of Medicine, South China University of Technology, Guangzhou, China.
  • Li M; Department of Hematology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
  • Chen X; Department of Hematology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
  • Geng S; Department of Hematology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
  • Lai P; Department of Hematology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
  • Weng J; Department of Hematology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
  • Du X; Department of Hematology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Clin Transl Sci ; 17(1): e13711, 2024 01.
Article em En | MEDLINE | ID: mdl-38129985

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sulfonamidas / Leucemia Mielomonocítica Crônica / Compostos Bicíclicos Heterocíclicos com Pontes Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sulfonamidas / Leucemia Mielomonocítica Crônica / Compostos Bicíclicos Heterocíclicos com Pontes Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article